Subtopic Deep Dive

DNA Topoisomerase II Poisons
Research Guide

What is DNA Topoisomerase II Poisons?

DNA Topoisomerase II poisons are anticancer agents like etoposide and doxorubicin that stabilize Topoisomerase II-DNA cleavage complexes, inducing persistent DNA double-strand breaks in proliferating cancer cells.

These drugs target Top2A and Top2B isoforms, with etoposide and anthracyclines forming ternary complexes that prevent DNA religation (Froelich-Ammon and Osheroff, 1995; 503 citations). Research spans enzyme mechanisms, resistance pathways, and toxicity profiles, including cardiotoxicity from doxorubicin (van der Zanden et al., 2020). Over 10 key papers from 1994-2022 detail mechanisms and clinical implications, with Longley and Johnston (2005) cited 1627 times on drug resistance.

Curated Papers

Key Challenges

Why It Matters

Etoposide and doxorubicin form the backbone of lymphoma and leukemia regimens, stabilizing Top2 cleavage complexes to trigger DSBs repaired via nonhomologous end joining, as shown with DNA-PK inhibitor NU7441 enhancing etoposide efficacy (Zhao et al., 2006; 439 citations). TOP2A amplification correlates with doxorubicin sensitivity in ErbB2-amplified breast cancers (Järvinen et al., 2000; 384 citations). Ongoing studies address resistance via Rad51 fork reversal (Zellweger et al., 2015; 672 citations) and doxorubicin cardiotoxicity (van der Zanden et al., 2020; 366 citations), guiding safer combination therapies.

Key Research Challenges

Chemotherapy Resistance Mechanisms

Tumors acquire resistance to Top2 poisons through TOP2A deletion or efflux pumps, limiting etoposide and doxorubicin efficacy (Longley and Johnston, 2005; 1627 citations). This intrinsic and acquired resistance reduces treatment response in relapsed cancers.

Cardiotoxicity from Anthracyclines

Doxorubicin induces cardiac damage via Top2B poisoning and DNA adducts, restricting cumulative dosing (van der Zanden et al., 2020; 366 citations). Mechanisms involve non-Top2 pathways exacerbating heart failure risk (Swift et al., 2006; 310 citations).

Isoform-Specific Targeting

Distinguishing Top2A (proliferating cells) from Top2B (post-mitotic tissues) toxicities remains unresolved, as poisons like ICRF-193 trap enzymes differently (Roca et al., 1994; 350 citations; Pommier et al., 2022; 411 citations).

Essential Papers

Molecular mechanisms of drug resistance

DB Longley, PG Johnston · 2005 · The Journal of Pathology · 1.6K citations

Abstract Resistance to chemotherapy limits the effectiveness of anti‐cancer drug treatment. Tumours may be intrinsically drug‐resistant or develop resistance to chemotherapy during treatment. Acqui...

Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells

Ralph Zellweger, Damian Dalcher, Karun Mutreja et al. · 2015 · The Journal of Cell Biology · 672 citations

Replication fork reversal protects forks from breakage after poisoning of Topoisomerase 1. We here investigated fork progression and chromosomal breakage in human cells in response to a panel of su...

Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism

Stacie J. Froelich-Ammon, Neil Osheroff · 1995 · Journal of Biological Chemistry · 503 citations

Although the one-dimensional sequence of DNA determines the genetic constitution of an organism, topological relationships within the double helix modulate virtually every physiological function of...

Anticancer Activity of Natural Compounds from Plant and Marine Environment

Anna Lichota, Krzysztof Gwoździński · 2018 · International Journal of Molecular Sciences · 456 citations

This paper describes the substances of plant and marine origin that have anticancer properties. The chemical structure of the molecules of these substances, their properties, mechanisms of action, ...

Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441

Yan Zhao, Huw D. Thomas, Michael A. Batey et al. · 2006 · Cancer Research · 439 citations

Abstract DNA double-strand breaks (DSB) are the most cytotoxic lesions induced by ionizing radiation and topoisomerase II poisons, such as etoposide and doxorubicin. A major pathway for the repair ...

Human topoisomerases and their roles in genome stability and organization

Yves Pommier, André Nussenzweig, Shunichi Takeda et al. · 2022 · Nature Reviews Molecular Cell Biology · 411 citations

Human topoisomerases comprise a family of six enzymes: two type IB (TOP1 and mitochondrial TOP1 (TOP1MT), two type IIA (TOP2A and TOP2B) and two type IA (TOP3A and TOP3B) topoisomerases. In this Re...

Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast Cancer

Tero A.H. Järvinen, Minna Tanner, Virpi Rantanen et al. · 2000 · American Journal Of Pathology · 384 citations

Reading Guide

Foundational Papers

Start with Froelich-Ammon and Osheroff (1995; 503 citations) for poison mechanisms and Roca et al. (1994; 350 citations) for clamp trapping, then Longley and Johnston (2005; 1627 citations) for resistance.

Recent Advances

Pommier et al. (2022; 411 citations) on isoform roles; van der Zanden et al. (2020; 366 citations) on doxorubicin toxicities; Zellweger et al. (2015; 672 citations) on fork reversal.

Core Methods

Cleavage complex assays (Froelich-Ammon 1995); DSB repair inhibition with NU7441 (Zhao 2006); TOP2A FISH in tumors (Järvinen 2000); Rad51 immunofluorescence for forks (Zellweger 2015).

How PapersFlow Helps You Research DNA Topoisomerase II Poisons

Discover & Search

Research Agent uses citationGraph on Froelich-Ammon and Osheroff (1995) to map 500+ citing papers on Top2 poison mechanisms, then findSimilarPapers reveals resistance links to Longley and Johnston (2005). exaSearch queries 'etoposide Top2A breast cancer resistance' for 250M+ OpenAlex papers filtered by citations.

Analyze & Verify

Analysis Agent runs readPaperContent on Zhao et al. (2006) to extract DSB repair data from etoposide, then verifyResponse with CoVe cross-checks claims against Pommier et al. (2022). runPythonAnalysis processes citation networks with pandas for resistance cluster stats; GRADE scores evidence strength for cardiotoxicity claims.

Synthesize & Write

Synthesis Agent detects gaps in Top2 isoform specificity across Järvinen et al. (2000) and Pommier et al. (2022), flagging contradictions on doxorubicin modes. Writing Agent uses latexEditText for regimen tables, latexSyncCitations for 10-paper bibliographies, and latexCompile for review drafts; exportMermaid diagrams Top2 clamp mechanisms from Roca et al. (1994).

Use Cases

"Analyze resistance rates in TOP2A-amplified breast cancers from doxorubicin trials"

Research Agent → searchPapers('TOP2A doxorubicin breast cancer') → Analysis Agent → runPythonAnalysis(pandas meta-analysis on 384-citation Järvinen et al. 2000 dataset) → researcher gets survival curves and odds ratios plot.

"Draft LaTeX figure of etoposide-Top2 cleavage complex with citations"

Synthesis Agent → gap detection (Froelich-Ammon 1995 + Pommier 2022) → Writing Agent → latexGenerateFigure + latexSyncCitations + latexCompile → researcher gets compiled PDF with mechanism diagram.

"Find GitHub repos modeling Top2 poison fork reversal"

Research Agent → paperExtractUrls(Zellweger et al. 2015) → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets runnable Python sims of Rad51 fork dynamics.

Automated Workflows

Deep Research workflow scans 50+ Top2 poison papers via searchPapers → citationGraph → structured report on resistance (Longley 2005). DeepScan applies 7-step CoVe to verify doxorubicin cardiotoxicity claims across van der Zanden (2020) and Swift (2006). Theorizer generates hypotheses on isoform-specific inhibitors from Roca (1994) + Pommier (2022).

Try Doxa for DNA Topoisomerase II Poisons Research

Frequently Asked Questions

What defines a DNA Topoisomerase II poison?

Agents like etoposide and doxorubicin that trap Top2-DNA cleavage complexes, preventing religation and causing DSBs (Froelich-Ammon and Osheroff, 1995).

What are key methods for studying Top2 poisons?

In vitro cleavage assays measure complex stabilization; yeast models test clamps (Roca et al., 1994); human cell fork reversal tracks genotoxicity (Zellweger et al., 2015).

What are seminal papers on Top2 poisons?

Froelich-Ammon and Osheroff (1995; 503 citations) on mechanisms; Longley and Johnston (2005; 1627 citations) on resistance; Pommier et al. (2022; 411 citations) on isoforms.